BrainVivo

Company Overview

Snapshot

Founded in January 2019 by Assaf (Assi) Horowitz and Yaniv Assaf, BrainVivo operates with 1–10 employees. The company has secured funding across three rounds. In June 2025, BrainVivo received follow-on investment from iAngels.

Business overview

BrainVivo develops neurotechnology to make human wisdom universally accessible and useful. The company's core technology blends MRI brain scans with real-world data to chart the brain’s biological neural networks, converting them into algorithmic models. These models are designed to mimic individual human intelligences, including sensory experiences, emotional responses, and personal perceptions. BrainVivo serves markets in Europe, the United States, and Asia, operating within the Business Software sector, with applications in IT, R&D, Data Solutions, and Health Tech & Life Sciences.

Strategic signal

BrainVivo's follow-on investment from iAngels in June 2025 signals continued investor confidence in its neurotechnology and its potential to digitize human wisdom. This funding suggests ongoing validation of BrainVivo's approach to creating algorithmic models from brain scans, which could accelerate its product development and market expansion in the competitive AI and health tech landscapes.

Company Intelligence Q&A

What is BrainVivo's core technology?

BrainVivo's core technology blends MRI brain scans with real-world data to map biological neural networks, converting them into algorithmic models that mimic human intelligence, including sensory and emotional responses.

When was BrainVivo founded and by whom?

BrainVivo was founded in January 2019 by Assaf (Assi) Horowitz and Yaniv Assaf.

What is one of BrainVivo's key use cases?

One of BrainVivo's key use cases is the automatic identification of fake faces and manipulated images, leveraging AI/ML to prevent identity fraud and enhance security in digital verification processes.